The Claim

Depletion of endogenous ovarian antigens prior to the detectable T cell response at day 5 does not prevent the induction of autoantibodies, indicating that ZP3 antigens located outside the ovaries are sufficient to stimulate autoantibody production.

Source: Rapid induction of autoantibodies by endogenous ovarian antigens and activated T cells: implication in autoimmune disease pathogenesis and B cell tolerance.

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
8score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

Removing ovarian antigens before the immune system detects them does not stop the production of certain autoantibodies, suggesting that similar antigens present outside the ovaries can trigger this response.

See the scientific wording

Depletion of endogenous ovarian antigens before detectable T cell response (day 5) does not prevent the induction of autoantibodies, suggesting these autoantibodies are stimulated by ZP3 antigens located outside the ovaries.

What the research says

1 study

  1. Study: Rapid induction of autoantibodies by endogenous ovarian antigens and activated T cells: implication in autoimmune disease pathogenesis and B cell tolerance.

    Even when scientists removed the ovaries before the immune system started reacting, the body still made antibodies against ZP3—meaning the antibodies must have been triggered by ZP3 hiding somewhere else in the body, not just in the ovaries.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.